Release Date: 03/10/12 11:10 Summary: Lapse of Unlisted Options Price Sensitive: No Download Document 214.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%